We previously reported CD200 is expressed in the pancreatic TME [33], and in this report, we are the first to show that CD200 is overexpressed on stromal, immune, and epithelial cells compared to cancer-adjacent tissues and normal tissues. The gene discussed is CD200; the disease is cancer.